ELYSIVIR
Pre-clinical- Indications
- COVID-19, HIV, Zika, Dengue
Company intelligence / Profile preview
Elysium Health develops science-backed consumer health products focused on healthy aging. Their flagship supplement Basis has been clinically shown to increase NAD+ levels. The company also offers cognitive, immune, metabolic supplements and an at-home biological age test using proprietary epigenetic algorithms. They have completed or are running over a dozen human clinical trials but do not market prescription therapeutics. Research collaborations include Mayo Clinic, Oxford University, Yale University, and MIT. Their scientific advisory board includes multiple Nobel laureates.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Elysium Cell Bio.